IS6085A - Lyfjablanda með kítósan óligómerum - Google Patents

Lyfjablanda með kítósan óligómerum

Info

Publication number
IS6085A
IS6085A IS6085A IS6085A IS6085A IS 6085 A IS6085 A IS 6085A IS 6085 A IS6085 A IS 6085A IS 6085 A IS6085 A IS 6085A IS 6085 A IS6085 A IS 6085A
Authority
IS
Iceland
Prior art keywords
oligomers
treatment
medication
compositions
chitosan oligomers
Prior art date
Application number
IS6085A
Other languages
English (en)
Icelandic (is)
Inventor
M. Einarsson Jon
Gíslason Johannes
Peter Martin
Original Assignee
Genis Ehf.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genis Ehf. filed Critical Genis Ehf.
Priority to IS6085A priority Critical patent/IS6085A/is
Priority to AT02777769T priority patent/ATE359797T1/de
Priority to EP02777769A priority patent/EP1435976B1/en
Priority to PCT/IS2002/000016 priority patent/WO2003026677A1/en
Priority to SI200230558T priority patent/SI1435976T1/sl
Priority to PT02777769T priority patent/PT1435976E/pt
Priority to KR10-2004-7004323A priority patent/KR20040062548A/ko
Priority to CA2507926A priority patent/CA2507926C/en
Priority to ES02777769T priority patent/ES2284935T3/es
Priority to JP2003530312A priority patent/JP4613008B2/ja
Priority to DK02777769T priority patent/DK1435976T3/da
Priority to DE60219653T priority patent/DE60219653T2/de
Priority to US10/490,637 priority patent/US7985741B2/en
Publication of IS6085A publication Critical patent/IS6085A/is
Priority to IS7193A priority patent/IS2783B/is
Priority to US13/164,397 priority patent/US8415326B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Materials Engineering (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IS6085A 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum IS6085A (is)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum
CA2507926A CA2507926C (en) 2001-09-26 2002-09-26 Pharmaceutical composition comprising chito-oligomers
ES02777769T ES2284935T3 (es) 2001-09-26 2002-09-26 Composicion farmaceutica que comprende quitooligomeros.
PCT/IS2002/000016 WO2003026677A1 (en) 2001-09-26 2002-09-26 Pharmaceutical composition comprising chito-oligomers
SI200230558T SI1435976T1 (sl) 2001-09-26 2002-09-26 Farmacevtski sestavek, ki obsega hito-oligomere
PT02777769T PT1435976E (pt) 2001-09-26 2002-09-26 Composição farmacêutica incluindo quito-oligómeros
KR10-2004-7004323A KR20040062548A (ko) 2001-09-26 2002-09-26 키토-올리고머를 함유하는 약학 조성물
AT02777769T ATE359797T1 (de) 2001-09-26 2002-09-26 Pharmazeutische zusammensetzung mit chito- oligomeren
EP02777769A EP1435976B1 (en) 2001-09-26 2002-09-26 Pharmaceutical composition comprising chito-oligomers
JP2003530312A JP4613008B2 (ja) 2001-09-26 2002-09-26 キト−オリゴマーを含む医薬組成物
DK02777769T DK1435976T3 (da) 2001-09-26 2002-09-26 Farmaceutisk sammensætning indeholdende chito-oligomerer
DE60219653T DE60219653T2 (de) 2001-09-26 2002-09-26 Pharmazeutische zusammensetzung mit chito-oligomeren
US10/490,637 US7985741B2 (en) 2001-09-26 2002-09-26 Pharmaceutical composition comprising chito-oligomers
IS7193A IS2783B (is) 2001-09-26 2004-03-22 Lyfjasamsetning sem nær yfir kító-fáliður
US13/164,397 US8415326B2 (en) 2001-09-26 2011-06-20 Pharmaceutical composition comprising chito-oligomers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum

Publications (1)

Publication Number Publication Date
IS6085A true IS6085A (is) 2003-03-27

Family

ID=36700489

Family Applications (2)

Application Number Title Priority Date Filing Date
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum
IS7193A IS2783B (is) 2001-09-26 2004-03-22 Lyfjasamsetning sem nær yfir kító-fáliður

Family Applications After (1)

Application Number Title Priority Date Filing Date
IS7193A IS2783B (is) 2001-09-26 2004-03-22 Lyfjasamsetning sem nær yfir kító-fáliður

Country Status (13)

Country Link
US (2) US7985741B2 (enExample)
EP (1) EP1435976B1 (enExample)
JP (1) JP4613008B2 (enExample)
KR (1) KR20040062548A (enExample)
AT (1) ATE359797T1 (enExample)
CA (1) CA2507926C (enExample)
DE (1) DE60219653T2 (enExample)
DK (1) DK1435976T3 (enExample)
ES (1) ES2284935T3 (enExample)
IS (2) IS6085A (enExample)
PT (1) PT1435976E (enExample)
SI (1) SI1435976T1 (enExample)
WO (1) WO2003026677A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002351576A1 (en) * 2001-12-13 2003-07-09 Ism Biopolymer Inc. Method of modulating release of saccharides and uses thereof
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
CN1909911A (zh) * 2003-10-01 2007-02-07 浩鼎生技公司 通过给予氨基糖治疗哺乳动物的疾病状态及其用途
JP2007525486A (ja) * 2003-11-24 2007-09-06 オプティマー・ファーマスーティカルズ・インコーポレイテッド 化合物の投与による哺乳動物の症状の処置及び化合物の使用方法
JP4496375B2 (ja) * 2004-05-21 2010-07-07 国立大学法人鳥取大学 創傷の治療又は処置のための薬剤
NZ565022A (en) * 2005-06-14 2011-04-29 Genis Ehf Compositions of partially deacetylated chitin derivatives
US7485718B2 (en) 2005-06-16 2009-02-03 E. I. Du Pont De Nemours And Company Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
WO2007001283A2 (en) * 2005-06-16 2007-01-04 E.I. Dupont De Nemours And Company Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
KR100831335B1 (ko) * 2006-06-22 2008-05-22 부경대학교 산학협력단 인간 피부 섬유아세포에서 메트릭스메탈로프로테이나제-2의 발현 및 활성을 억제시키는키토올리고사카라이드 화합물 및 이를 함유한 메트릭스메탈로프로테이나제-2 억제제
CA2731201C (en) * 2008-07-18 2018-10-16 Genis Ehf. Composition for treating autoimmune disorders
KR20100060634A (ko) * 2008-11-28 2010-06-07 (주)아모레퍼시픽 미토콘드리아 활성화를 위한 조성물
KR101729137B1 (ko) * 2009-07-28 2017-04-26 (주)아모레퍼시픽 키토올리고당을 함유하는 피로회복용 조성물
CA2838059C (en) 2011-06-03 2020-08-25 Maguire Abbey, Llc Method, composition, and articles for improving joint lubrication
BR112014005400B1 (pt) 2011-09-08 2019-10-01 Novozymes Bioag A/S Método para aumentar o crescimento e/ou rendimento de soja
UA116193C2 (uk) 2011-09-14 2018-02-26 Новозаймс Біоаг А/С Композиція для обробки рослини або насінини рослини та спосіб стимулювання росту рослин
IN2014CN02911A (enExample) * 2011-09-23 2015-07-03 Novozymes Bioag As
US9055746B2 (en) 2011-09-23 2015-06-16 Novozymes Bioag A/S Chitooligosaccharides and methods for use in enhancing plant growth
CN104470550A (zh) 2012-04-23 2015-03-25 杰尼斯公共有限公司 作为骨移植替代物的含有部分脱乙酰壳多糖的自硬化生物活性接合剂组合物
JP6285497B2 (ja) * 2016-06-07 2018-02-28 株式会社エバーライフ 鶏冠抽出物含有経口組成物及び鶏冠抽出物の香味に由来する摂取困難性の改善方法
KR101673368B1 (ko) 2016-07-14 2016-11-08 김기혁 공정가스 반응물의 콜드트랩 장치
US20260191887A1 (en) * 2022-04-21 2026-07-09 Therapeutikos, Inc. Methods of treating inflammation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5919122B2 (ja) * 1976-10-12 1984-05-02 味の素株式会社 水溶性部分脱アセチル化キチン及びその製造法
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
JP2527317B2 (ja) * 1986-12-19 1996-08-21 ライオン株式会社 骨疾患治療剤
US6184037B1 (en) * 1996-05-17 2001-02-06 Genemedicine, Inc. Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
US6117851A (en) * 1996-12-13 2000-09-12 Lescarden Inc. Treatment of osteoarthritis by administering poly-N-acetyl-D-glucosamine
JP3062592B2 (ja) * 1997-05-30 2000-07-10 農林水産省食品総合研究所長 ２−アセチルアミノ−４−Ｏ−（２−アミノ−２−デオキシ−β−Ｄ −グルコピラノシル）−２−デオキシ−Ｄ −グルコースおよびその塩の製造法
US6492350B2 (en) * 2000-01-27 2002-12-10 Jdc (Hawaii) Inc. Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
EP1127574A1 (en) * 2000-02-22 2001-08-29 Food Industry Research and Development Institute Use of chitinous materials for inhibiting cellular nitric oxide production
CA2313836C (en) * 2000-03-15 2009-06-09 Cargill, Incorporated Chitosan and method of preparing chitosan
US20020119949A1 (en) * 2001-02-26 2002-08-29 Asa Hellman Prophylactic teat treatment
NZ565022A (en) 2005-06-14 2011-04-29 Genis Ehf Compositions of partially deacetylated chitin derivatives

Also Published As

Publication number Publication date
EP1435976B1 (en) 2007-04-18
DE60219653D1 (de) 2007-05-31
DE60219653T2 (de) 2008-01-03
US7985741B2 (en) 2011-07-26
IS7193A (is) 2004-03-22
US8415326B2 (en) 2013-04-09
KR20040062548A (ko) 2004-07-07
CA2507926C (en) 2011-12-20
ATE359797T1 (de) 2007-05-15
DK1435976T3 (da) 2007-08-27
EP1435976A1 (en) 2004-07-14
WO2003026677A1 (en) 2003-04-03
US20110257381A1 (en) 2011-10-20
ES2284935T3 (es) 2007-11-16
CA2507926A1 (en) 2003-04-03
US20050004073A1 (en) 2005-01-06
JP2005507891A (ja) 2005-03-24
IS2783B (is) 2012-05-15
SI1435976T1 (sl) 2007-08-31
PT1435976E (pt) 2007-06-28
JP4613008B2 (ja) 2011-01-12

Similar Documents

Publication Publication Date Title
IS7193A (is) Lyfjablanda með kítósan óligómerum
EP2085780A3 (en) Methods and products related to low molecular weight heparin
EA202193053A1 (ru) Хитозан и его применения
IL150257A0 (en) Galactomaninan oligosaccharides, pharmaceutical compositions containing the same and methods for the production thereof
WO2002018448A3 (en) Percarboxylated polysaccharides, and a process for their preparation
ATE479453T1 (de) Polymermischungen von anionischen und kationischen polysacchariden und verwendung davon
Kim et al. Purification and characteristics of two types of chitosanases from Aspergillus fumigatus KH-94
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
MX375577B (es) Composiciones de derivados de quitina parcialmente desacetilados.
WO2004105737A3 (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
ATE441333T1 (de) Zusammensetzung enthaltend oligosaccharide als lísliche ballaststoffe zur verwendung gegen muskelschwund
JP2005507891A5 (enExample)
IT1303249B1 (it) Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
NO20040381L (no) Kitosanfremstilling
TW200510012A (en) Aqua gel comprising temperature effect
DE60039201D1 (de) Herstellung von Chitin und Chitosan
DK1366082T3 (da) Höjsulfaterede derivater af K5-polysaccharid og deres fremstilling
DK1165112T3 (da) Modulatorer af polysaccharider og anvendelser deraf
DE602006018058D1 (de) Viskosupplementation mit algen-polysacchariden bei der behandlung von arthritis
EP2301554A8 (en) Composition for the treatment of osteoarthritis
EP1411956B8 (en) Use of oversulfated polysaccharides as inhibitors of hiv
JP2008308430A5 (enExample)
WO2002069984A3 (de) Verwendung von hyaluronsäure-uroniden zur behandlung von entzündlichen vorgängen
CA2445331A1 (en) Exopolysaccharide production
ATE552004T1 (de) Oral verabreichbare heparinderivate